33 articles for G Zheng
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
1,4-Diphenalkylpiperidines: A new scaffold for the design of potent inhibitors of the vesicular monoamine transporter-2.
University of Kentucky
Lobelane analogues containing 4-hydroxy and 4-(2-fluoroethoxy) aromatic substituents: Potent and selective inhibitors of [(3)H]dopamine uptake at the vesicular monoamine transporter-2.
University of Arkansas For Medical Sciences
Muscarinic acetylcholine receptor binding affinities of pethidine analogs.
University of Kentucky
Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.
University of Arkansas For Medical Sciences
Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporter.
University of Kentucky
Discovery of non-peptide, small molecule antagonists ofa9a10 nicotinic acetylcholine receptors as novel analgesics for the treatment of neuropathic and tonic inflammatory pain.
University of Kentucky
Novel bis-, tris-, and tetrakis-tertiary amino analogs as antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release.
University of Kentucky
Tetrakis-azaaromatic quaternary ammonium salts: novel subtype-selective antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release.
University of Kentucky
Synthesis and evaluation of a series of homologues of lobelane at the vesicular monoamine transporter-2.
University of Kentucky
Discovery of a Highly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8.
University of Florida
Recent advances in the development of EGFR degraders: PROTACs and LYTACs.
Zhejiang University
Des-keto lobeline analogs with increased potency and selectivity at dopamine and serotonin transporters.
University of Kentucky
Synthesis and evaluation of a series of tropane analogues as novel vesicular monoamine transporter-2 ligands.
University of Kentucky
The characterization of a novel rigid nicotine analog with alpha7-selective nAChR agonist activity and modulation of agonist properties by boron inclusion.
University of Florida
Design, synthesis, and bioactivity evaluation of macrocyclic benzo[b]pyrido[4,3-e][1,4]oxazine derivatives as novel Pim-1 kinase inhibitors.
Beijing University of Chemical Technology
Rational Remodeling of Atypical Scaffolds for the Design of Photoswitchable Cannabinoid Receptor Tools.
Shanghaitech University
Discovery of Selective, Covalent FGFR4 Inhibitors with Antitumor Activity in Models of Hepatocellular Carcinoma.
Bristol Myers Squibb
Design, synthesis and biological activity evaluation of novel 4-((1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl) oxy) pyridine-2-yl) amino derivatives as potent transforming growth factor-β (TGF-β) type I receptor inhibitors.
China Pharmaceutical University
Synthesis and in vitro evaluation of water-soluble 1,4-diphenethylpiperazine analogs as novel inhibitors of the vesicular monoamine transporter-2.
University of Kentucky
Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M
University of Kentucky
New histone demethylase LSD1 inhibitor selectively targets teratocarcinoma and embryonic carcinoma cells.
University of Nevada
Fused tri-cyclic compound as PDE3/PDE4 dual inhibitor
Chia Tai Tianqing Pharmaceutical Group
TRICYCLIC PYRIMIDINES AS CYCLIN-DEPENDENT KINASE 7 (CDK7) INHIBITORS
Janssen Pharmaceutica
INTEGRIN INHIBITORS AND USES THEREOF IN COMBINATION WITH OTHER AGENTS
Pliant Therapeutics
Benzimidazole compounds and derivatives as EGFR inhibitors
Boehringer Ingelheim International
Heterocyclic derivatives and their use in the treatment of neurological disorders
Novartis